[Hyp3]-bradykinin and [Hyp3]-Lys-bradykinin interact with B2-bradykinin receptors and stimulate inositol phosphate production in cultured human fibroblasts
- FEBS Lett. 1990 Mar 12;262(1):111-4. doi: 10.1016/0014-5793(90)80166-g.
- 1. Kinderklinik im Dr. von Hauner'schen Kinderspital der Universität München, Abteiung für Klinische Biochemie, FRG.
The recently isolated, naturally occurring peptide Hormones [Hyp3]-bradykinin and [Hyp3]-Lys-bradykinin were investigated for their agonist activity on solubilized binding sites from human fibroblasts. Both ligands competed with [3H]bradykinin binding in a dose-dependent fashion with potencies similar to bradykinin (BK) and Lys-BK. Biological activity was assessed by determination of inositol phosphate accumulation and cyclic 3',5'-adenosine monophosphate synthesis in intact cultured cells. Stimulation by the hydroxylated peptides resulted in a pronounced accumulation of both parameters with similar effectiveness as BK and Lys-BK. These results indicate that [Hyp3]-BK and [Hyp3]-Lys-BK are agonists at the Bradykinin Receptor system with properties comparable to their non-hydroxylated analogues. This suggests that hydroxylation of kinins does not alter receptor interaction or signal transduction in cultured human fibroblasts.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Bradykinin Receptor
-
target: Bradykinin ReceptorResearch Areas: Inflammation/Immunology